![]() |
|
|
Vol. 60, Issue 5, 999-1007, November 2001
-Adrenergic Ligands with Distinct Inverse Efficacies
Département de Biochimie and le Groupe de Recherches sur le
Système Nerveux Autonome, Université de Montréal,
Montréal, Québec, Canada
Allosteric models of G protein-coupled receptors predict that G protein
influences the spontaneous isomerization between inactive (R) and
active (R*) conformations. Since inverse agonists have been proposed to
preferentially bind to the inactive and uncoupled form(s), changes in
the G protein content should influence the binding properties of these
ligands. To test this hypothesis, we systematically assessed the effect
of G proteins on the binding of
2-adrenergic ligands
with distinct levels of inverse efficacy. Recombinant baculoviruses
encoding the human
2-adrenoreceptor (
2AR)
were expressed alone or in combination with G protein subunits in Sf9
cells. Coexpression with the G protein
s
1
2 did not influence the relative efficacy of the ligands to inhibit the adenylyl cyclase but induced considerable decrease in number of sites detected by
[3H]ICI 118551, [3H]propranolol, and
125I-cyanopindolol. This loss was proportional to the
inverse efficacy of the ligand used as the radiotracer in the assay.
The addition of Gpp(NH)p inhibited the effects of G protein
overexpression indicating that the G proteins acted allosterically.
Consistent with this notion, Western blot analysis revealed that
coexpression with the G proteins was not accompanied by a loss of
immunoreactive
2AR. Such allosteric effects of the G
proteins were also observed in mammalian cells expressing endogenous
level of G proteins indicating that the phenomenon is not unique to
overexpression systems. Taken together, these results demonstrate that
the apparent receptor number detected by radiolabeled inverse agonists
is affected by the content in G proteins as a result of their influence
on R/R* isomerization.
This article has been cited by other articles:
![]() |
J. G. Baker, I. P. Hall, and S. J. Hill Temporal Characteristics of cAMP Response Element-Mediated Gene Transcription: Requirement for Sustained cAMP Production Mol. Pharmacol., April 1, 2004; 65(4): 986 - 998. [Abstract] [Full Text] |
||||
![]() |
T. Kenakin Efficacy as a Vector: the Relative Prevalence and Paucity of Inverse Agonism Mol. Pharmacol., January 1, 2004; 65(1): 2 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Baker, I. P. Hall, and S. J. Hill Agonist and Inverse Agonist Actions of {beta}-Blockers at the Human {beta}2-Adrenoceptor Provide Evidence for Agonist-Directed Signaling Mol. Pharmacol., December 1, 2003; 64(6): 1357 - 1369. [Abstract] [Full Text] [PDF] |
||||